Please use this identifier to cite or link to this item:
http://hdl.handle.net/2067/1843
DC Field | Value | Language |
---|---|---|
dc.contributor.author | D'Amici, Gian Maria | - |
dc.contributor.author | Timperio, Anna Maria | - |
dc.contributor.author | Gevi, Federica | - |
dc.contributor.author | Grazzini, Giuliano | - |
dc.contributor.author | Zolla, Lello | - |
dc.date.accessioned | 2011-04-01T06:45:53Z | - |
dc.date.available | 2011-04-01T06:45:53Z | - |
dc.date.issued | 2010 | - |
dc.identifier.citation | D'Amici, G.M. et al. 2010. Recombinant clotting factor VIII concentrates: Heterogeneity and high-purity evaluation. "Electrophoresis" 31(16): 2730-2739 | it |
dc.identifier.issn | 0173-0835 | - |
dc.identifier.uri | http://hdl.handle.net/2067/1843 | - |
dc.description | L'artcoo è disponibile sul sito dell'editore http://onlinelibrary.wiley.com/ | it |
dc.description.abstract | Factor VIII is an important glycoprotein involved in hemostasis. Insertion of expression vectors containing either the full-length cDNA sequence of human factor VIII (FLrFVIII) or B-domain deleted (BDDrFVIII) into mammalian cell lines results in the production of recombinant factor VIII (rFVIII) for therapeutic usage. Three commercially available rFVIII concentrates (Advates, Helixate NexGens and Refactos), either FLrFVIII or BDDrFVIII, were investigated by 1- and 2-DE and MS. The objective of this study was to compare the heterogeneity and the high purity of both rFVIII preparations before and after thrombin digestion. In particular, the 2-D gel was optimized to better highlight the presence of contaminants and many unexpected proteins. Recombinant strategies consisting of insertion of expression vectors containing BDDrFVIII and FLrFVIII resulted in homogeneous and heterogeneous protein products, respectively, the latter consisting in a heterogeneous mixture of various B-domain-truncated forms of the molecule. Thrombin digestion of all the three rFVIII gave similar final products, plus one unexpected fragment of A2 domain missing 11 amino acids. Regarding the contaminants, Helixate NexGens showed the presence of impurities, such as Hsp70 kDa, haptoglobin and proapolipoprotein; Refactos showed glutathione S-transferase and b-lactamase, whereas Advates apparently did not contain any contaminants. The proteomic approach will contribute to improving the quality assurance and manufacturing processes of rFVIII concentrates. In this view, the 2-DE is mandatory for revealing the presence of contaminants. | it |
dc.language.iso | en | it |
dc.publisher | Wiley-Blackwell | it |
dc.subject | 2-DE | it |
dc.subject | Hemophilia A | it |
dc.subject | Proteomics | it |
dc.subject | Recombinant factor VIII | it |
dc.title | Recombinant clotting factor VIII concentrates: Heterogeneity and high-purity evaluation | it |
dc.type | Article | it |
dc.identifier.doi | 10.1002/elps.201000216 | it |
item.fulltext | With Fulltext | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | open | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
Appears in Collections: | DISA - Archivio della produzione scientifica |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
D'amici et al.pdf | 82.04 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
5
21
Last Week
0
0
Last month
0
0
checked on Sep 18, 2023
Page view(s)
180
Last Week
0
0
Last month
4
4
checked on Mar 27, 2024
Download(s)
229
checked on Mar 27, 2024
Google ScholarTM
Check
Altmetric
All documents in the "Unitus Open Access" community are published as open access.
All documents in the community "Prodotti della Ricerca" are restricted access unless otherwise indicated for specific documents